Lupin launches Turqoz (Norgestrel and Ethinyl Estradiol) Tablets USP in the US

Turqoz Tablets USP 0.3 mg/0.03 mg is a contraceptive drug indicated to prevent pregnancy
Lupin launches Turqoz (Norgestrel and Ethinyl Estradiol) Tablets USP in the US

Lupin announced the launch of Turqoz (Norgestrel and Ethinyl Estradiol) Tablets USP, 0.3 mg/0.03 mg, after having received an approval from the United States Food and Drug Administration (US FDA).

Turqoz (Norgestrel and Ethinyl Estradiol) Tablets USP, 0.3 mg/0.03 mg is the generic equivalent of Lo/Ovral-28 (Norgestrel and Ethinyl Estradiol) Tablets, 0.3 mg/0.03 mg of Wyeth Pharmaceuticals LLC and is a contraceptive drug indicated to prevent pregnancy.

Norgestrel and Ethinyl Estradiol Tablets USP (RLD: Lo/Ovral-28) had estimated annual sales of $33 million in the US (IQVIA MAT October 2023).

LupinNorgestrel and Ethinyl Estradiol Tablets USPTurqoz tabletsUSUS Pharma market
Comments (0)
Add Comment